
  
    
      
        Background_NNP
        Ion_NNP channels_NNS located_VBN in_IN the_DT plasma_NN membrane_NN provide_VB one_CD
        means_VBZ to_TO mediate_VB cellular_JJ adaptation_NN to_TO local_JJ environmental_JJ
        changes_NNS ._. Voltage-gated_NNP K_NNP +_NN channels_NNS in_IN non-nerve_JJ ,_, non-muscle_JJ
        cells_NNS play_VBP crucial_JJ roles_NNS in_IN cell_NN development_NN ,_,
        proliferation_NN ,_, migration_NN ,_, volume_NN regulation_NN ,_, as_RB well_RB as_IN
        maintenance_NN of_IN membrane_NN potential_NN and_CC cell_NN viability_NN ._. This_DT
        is_VBZ in_IN part_NN because_IN these_DT channels_NNS regulate_VB the_DT cytoplasmic_JJ
        concentrations_NNS of_IN K_NNP +_NN ,_, Ca_MD 2_CD +_NN ,_, and_CC Na_NNP +_NN ions_NNS [_NN 1_CD 2_CD 3_CD 4_CD 5_CD 6_CD 7_CD
        8_CD 9_CD 10_CD ]_NN ._. The_DT diversity_NN of_IN voltage-gated_JJ K_NNP +_NN channels_NNS and_CC
        currents_NNS present_JJ in_IN these_DT "_'' non-excitable_JJ "_'' (_( non-muscle_JJ ,_,
        non-nerve_JJ )_) cells_NNS is_VBZ impressive_JJ ._. Thus_RB ,_, the_DT assignment_NN of_IN
        specific_JJ functions_NNS to_TO particular_JJ subclasses_NNS of_IN K_NNP +_NN channel_NN
        proteins_NNS represents_VBZ a_DT significant_JJ challenge_NN [_NN 4_CD 10_CD 11_CD 12_CD 13_CD
        14_CD 15_CD 16_CD ]_NN ._.
        Voltage-gated_NNP K_NNP +_NN currents_NNS with_IN distinct_JJ
        electrophysiological_JJ and_CC pharmacological_JJ properties_NNS are_VBP
        present_JJ in_IN granulosa_NN cells_NNS (_( GC_NNP )_) ,_, and_CC modulate_VBP resting_VBG
        membrane_NN potential_JJ [_NN 4_CD 12_CD 13_CD 16_CD 17_CD ]_NN ._. Furthermore_RB ,_,
        selective_JJ antagonism_NN of_IN GC_NNP K_NNP +_NN channels_NNS with_IN distinct_JJ
        molecular_JJ correlates_NNS ,_, electrophysiological_JJ properties_NNS and_CC
        expression_NN patterns_NNS can_MD influence_VB differentially_RB GC_NNP
        proliferation_NN ,_, steroidogenic_JJ capability_NN ,_, and_CC apoptosis_NNS [_NN 17_CD
        18_CD ]_NN ._. Our_PRP$ laboratory_NN has_VBZ previously_RB identified_VBN two_CD
        distinct_JJ delayed_VBN rectifier_NN K_NNP +_NN currents_NNS in_IN pig_NN GC_NNP :_: a_DT slow_JJ
        current_JJ (_( I_NN 
        Ks_NNP )_) associated_VBN with_IN channels_NNS formed_VBN by_IN
        co-assembly_JJ of_IN KCNQ_NNP 1_CD pore-forming_JJ and_CC KCNE_NNP 1_CD accessory_JJ
        proteins_NNS ,_, and_CC an_DT ultra-rapid_JJ current_JJ (_( I_NN 
        Kur_NNP )_) formed_VBN by_IN co-assembly_JJ of_IN KCNA_NNP
        pore-forming_JJ and_CC KCNAB_NNP accessory_JJ proteins_NNS [_NN 4_CD ]_NN ._. Moreover_RB ,_,
        we_PRP have_VBP shown_VBN that_IN selective_JJ block_NN of_IN I_PRP 
        Ks_NNP enhances_VBZ basal_NN progesterone_NN
        synthesis_NN ,_, while_IN complete_JJ block_NN of_IN both_DT I_PRP 
        Ks_NNP and_CC I_PRP 
        Kur_NNP accelerates_VBZ apoptosis_NNS [_NN 18_CD ]_NN ._.
        Here_RB ,_, our_PRP$ goal_NN was_VBD to_TO determine_VB the_DT functional_JJ effects_NNS
        of_IN antagonizing_VBG GC_NNP K_NNP +_NN channels_NNS formed_VBN by_IN KCNA_NNP vs_NNS ._. KCNQ_NNP
        family_NN proteins_NNS ._. To_TO this_DT end_NN ,_, we_PRP treated_VBD primary_JJ cultures_NNS
        of_IN GC_NNP and_CC monolayers_NNS of_IN the_DT immortalized_JJ granulosa_NN cell_NN
        line_NN PGC-_NNP 2_CD [_NN 19_CD ]_NN with_IN the_DT K_NNP +_NN channel_NN antagonist_NN
        4_CD -_: aminopyridine_NN (_( 4_CD -_: AP_NNP )_) ._. 4_LS -_: aminopyridine_NN ,_, at_IN millimolar_NN
        concentrations_NNS ,_, completely_RB inhibits_NNS K_NNP +_NN currents_NNS conducted_VBN
        by_IN heterologously_RB expressed_VBD KCNA_NNP channels_NNS and_CC native_JJ GC_NNP I_PRP 
        Kur_NNP ,_, but_CC lacks_VBZ significant_JJ effects_NNS on_IN
        native_JJ GC_NNP I_PRP 
        Ks_NNP [_NN 4_CD 12_CD 13_CD 20_CD ]_NN ._. Kusaka_NNP showed_VBD that_DT
        antagonism_NN of_IN 4_CD -_: AP_NNP sensitive_JJ slowly_RB inactivating_VBG delayed_VBN
        rectifier_NN K_NNP +_NN currents_NNS suppressed_VBD both_DT basal_NN and_CC luteinizing_VBG
        hormone_NN (_( LH_NNP )_) -_: stimulated_VBN progesterone_NN production_NN [_NN 21_CD ]_NN ._. In_IN
        this_DT report_NN ,_, we_PRP extend_VBP those_DT findings_NNS by_IN demonstrating_VBG 4_CD -_: AP_NNP
        inhibition_NN of_IN follicle_NN stimulating_VBG hormone_NN (_( FSH_NNP )_) -_: stimulated_VBN
        progesterone_NN production_NN ,_, and_CC by_IN elucidating_VBG the_DT underlying_VBG
        mechanisms_NNS ._.
      
      
        Methods_NNP
        
          Reagents_NNP
          Cell_NNP culture_NN media_NNS ,_, supplements_NNS ,_, phosphate-buffered_JJ
          saline_NN (_( PBS_NNP ,_, 10_CD X_NNP )_) and_CC sera_NN were_VBD obtained_VBN from_IN Life_NNP
          Technologies_NNPS (_( Gaithersburg_NNP ,_, MD_NNP )_) unless_IN stated_VBN otherwise_RB ._.
          Chemicals_NNS were_VBD obtained_VBN from_IN Sigma_NNP (_( St_NNP ._. Louis_NNP ,_, MO_NNP )_) unless_IN
          stated_VBN otherwise_RB ._. Regular_JJ pork_NN insulin_NN (_( 100_CD units_NNS /_NN mL_NN )_) was_VBD
          obtained_VBN from_IN Eli_NNP Lilly_NNP (_( Indianapolis_NNP ,_, IN_IN )_) ._. PBFI-AM_NNP
          (_( 1_CD ,_, 3_CD -_: Benzenedicarboxylic_NNP acid_NN ,_,
          4_CD ,_, 4_CD '_POS -_: [_NN 1_CD ,_, 4_CD ,_, 10_CD ,_, 13_CD -_: tetraoxa-_NN 7_CD ,_, 16_CD -_: diazacyclooctadecane-_NN 7_CD ,_, 16_CD -_: diylbis_NNS (_( 5_CD -_: methoxy-_NN 6_CD ,_, 2_CD -_: benzofurandiyl_NN )_) ]_NN bis-_NN ,_,
          tetrakis_NNS [_NN (_( acetyloxy_NN )_) methyl_NN ]_NN ester_NN )_) and_CC DiBAC_NNP 
          4_CD (_( 3_LS )_) (_( bis-_NN (_( 1_CD ,_, 3_CD -_: dibutylbarbituric_JJ
          acid_NN )_) trimethine_NN oxonol_NN )_) were_VBD obtained_VBN from_IN Molecular_NNP
          Probes_NNP (_( Eugene_NNP ,_, OR_NNP )_) ._. Primary_JJ antibodies_NNS were_VBD obtained_VBN
          from_IN commercial_JJ sources_NNS for_IN detection_NN of_IN proliferating_VBG
          cell_NN nuclear_JJ antigen_NN (_( PCNA_NNP ,_, Oncogene_NNP Science_NNP ,_, Cambridge_NNP ,_,
          MA_NNP )_) and_CC actin_NN (_( Sigma_NNP )_) ._. Nitrocellulose_NNP membranes_NNS (_( Hybond_NNP
          ECL_NNP )_) ,_, secondary_JJ antibodies_NNS ,_, enhanced_JJ chemiluminescence_NN
          (_( ECL_NNP )_) reagent_NN ,_, and_CC film_NN (_( Hyperfilm_NNP ECL_NNP )_) were_VBD obtained_VBN
          from_IN Amersham_NNP Pharmacia_NNP Biotech_NNP (_( Piscataway_NNP ,_, NJ_NNP )_) ._. Porcine_NNP
          FSH_NNP (_( 2039_CD IU_NNP /_NN mg_NN )_) was_VBD obtained_VBN from_IN the_DT National_NNP Hormone_NNP
          and_CC Pituitary_NNP Program_NNP (_( NHPP_NNP )_) ._. PGC-_NNP 2_CD cells_NNS were_VBD provided_VBN
          by_IN B_NNP ._. R_NN ._. Downey_NNP (_( McGill_NNP University_NNP ,_, Montreal_NNP ,_, Canada_NNP )_) ._.
          Antibody_NNP directed_VBD against_IN steroidogenic_JJ acute_JJ regulatory_JJ
          protein_NN (_( StAR_NNP )_) was_VBD a_DT gift_NN from_IN D_NNP ._. B_NNP ._. Hales_NNP (_( University_NNP of_IN
          Illinois_NNP ,_, Chicago_NNP )_) ._.
        
        
          GC_NNP Isolation_NNP and_CC Culture_NNP
          Porcine_NNP ovaries_NNS were_VBD collected_VBN at_IN a_DT local_JJ
          slaughterhouse_NN ,_, and_CC GC_NNP were_VBD isolated_VBN using_VBG techniques_NNS
          described_VBD previously_RB in_IN detail_NN [_NN 4_CD 18_CD ]_NN ._. Briefly_NNP ,_, small_JJ
          (_( 1_CD -_: 3_CD mm_NN diameter_NN )_) to_TO medium_NN (_( 4_CD -_: 6_CD mm_NN diameter_NN )_) follicles_NNS
          were_VBD aspirated_JJ by_IN hand_NN using_VBG a_DT 19_CD -_: gauge_VB needle_NN attached_VBN
          to_TO a_DT 10_CD cc_NN syringe_NN ._. GC_NNP were_VBD separated_JJ from_IN follicular_NN
          fluid_JJ by_IN centrifugation_NN at_IN 500_CD ×_NN g_SYM for_IN 5_CD minutes_NNS ._. Cells_NNP
          were_VBD washed_VBN twice_RB with_IN a_DT 1_CD :_: 1_CD mixture_NN of_IN Ham_NNP F_NNP 10_CD nutrient_NN
          medium_NN and_CC Dulbecco_NNP modified_VBN Eagle_NNP medium_NN (_( DMEM_NNP )_)
          containing_VBG 4_CD -_: (_( 2_CD -_: Hydroxyethyl_NNP )_) piperazine-_NN 1_CD -_: ethanesulfonic_JJ
          acid_NN (_( HEPES_NNP ,_, 25_CD mM_NN )_) ,_, penicillin_NN (_( 50_CD U_NNP /_NN ml_NN )_) and_CC
          streptomycin_NN (_( 50_CD μg_NN /_NN ml_NN )_) ._. Culture_NNP conditions_NNS for_IN GC_NNP were_VBD
          similar_JJ to_TO those_DT described_VBD previously_RB by_IN our_PRP$ laboratory_NN
          and_CC others_NNS [_NN 4_CD 18_CD 22_CD 23_CD ]_NN ._. The_DT basic_JJ culture_NN medium_NN
          consisted_VBD of_IN HEPES-buffered_NNP DMEM_NNP :_: F_NN 10_CD (_( 1_CD :_: 1_LS )_) supplemented_JJ
          with_IN fetal_JJ bovine_JJ serum_NN (_( FBS_NNP ,_, 10_CD %_NN )_) ,_, penicillin_NN (_( 50_CD U_NNP /_NN ml_NN )_) ,_,
          streptomycin_NN (_( 50_CD μg_NN /_NN ml_NN )_) ,_, gentamicin_NN (_( 57_CD ng_NN /_NN ml_NN )_) and_CC
          amphotericin_NN (_( 2_CD ._. 5_LS μg_NN /_NN ml_NN )_) ._.
          Freshly_NNP isolated_VBD GC_NNP were_VBD plated_JJ in_IN the_DT basic_JJ
          serum-supplemented_JJ culture_NN media_NNS on_IN collagen-coated_JJ
          24_CD -_: well_RB (_( 500_CD μl_NN /_NN well_RB )_) or_CC 6_CD -_: well_RB (_( 2_CD ml_NN /_NN well_RB )_) culture_NN
          dishes_NNS ,_, and_CC incubated_JJ at_IN 37_CD °_NN C_NNP in_IN a_DT humidified_JJ atmosphere_NN
          of_IN 5_CD %_NN CO_NNP 
          2_CD and_CC air_NN ._. In_IN every_DT experiment_NN ,_, cells_NNS
          were_VBD plated_JJ at_IN equal_JJ density_NN for_IN each_DT treatment_NN group_NN ._.
          Plating_NNP density_NN between_IN experiments_NNS varied_VBD from_IN 2_CD ×_NN 10_CD
          4_CD cells_NNS /_NN well_RB /_NN 24_CD -_: multiwell_NN to_TO 1_CD ×_NN 10_CD
          6_CD cells_NNS /_NN well_RB /_NN 6_CD -_: multiwell_NN ._. Culture_NNP wells_NNS in_IN the_DT 6_CD -_: multiwell_NN
          clusters_NNS had_VBD a_DT well_JJ diameter_NN of_IN 34_CD ._. 8_CD mm_NN and_CC a_DT growth_NN area_NN
          of_IN 9_CD ._. 4_CD cm_NN 2_CD ,_, while_IN culture_NN wells_NNS in_IN the_DT 24_CD -_: multiwell_NN
          clusters_NNS had_VBD a_DT well_JJ diameter_NN of_IN 15_CD ._. 6_CD mm_NN and_CC a_DT growth_NN area_NN
          of_IN 1_CD ._. 9_CD cm_NN 2_CD ._. The_DT culture_NN media_NNS were_VBD changed_VBN 16_CD h_NN after_IN
          plating_VBG to_TO fresh_JJ serum-supplemented_JJ media_NNS that_WDT contained_VBD
          either_DT vehicle_NN or_CC treatment_NN (_( s_VBZ )_) ._. Media_NNP were_VBD collected_VBN and_CC
          replaced_VBN at_IN 24_CD h_NN intervals_NNS thereafter_RB ._. 4_LS -_: AP_NNP was_VBD dissolved_VBN
          directly_RB into_IN the_DT culture_NN media_NNS on_IN the_DT day_NN of_IN use_NN ,_, and_CC
          the_DT pH_NN was_VBD readjusted_JJ to_TO 7_CD ._. 4_CD with_IN saturated_VBD HCl_NNP after_IN
          addition_NN of_IN drug_NN ._. DIDS_NNP (_( 4_CD '_POS ,_, 4_CD '_POS
          diisothicyanato-stilbene-_JJ 2_CD -_: 2_CD '_POS -_: disulfonic_JJ acid_NN )_) was_VBD
          diluted_VBN into_IN culture_NN media_NNS from_IN a_DT 200_CD X_NNP aqueous_JJ stock_NN ._.
          Stock_NN solutions_NNS of_IN forskolin_NN (_( 10_CD mM_NN )_) and_CC
          3_CD -_: isobutyl-_NN 1_CD -_: methylxanthine_NN (_( IBMX_NNP ,_, 80_CD mM_NN )_) were_VBD in_IN
          DMSO_NNP ._.
          In_IN a_DT subset_NN of_IN experiments_NNS ,_, GC_NNP were_VBD cultured_JJ in_IN a_DT
          defined_VBN serum-free_JJ medium_NN of_IN HEPES-buffered_NNP DMEM_NNP :_: F_NN 10_CD
          (_( 1_CD :_: 1_LS )_) containing_VBG insulin_NN (_( 300_CD mU_NN /_NN ml_NN )_) ,_, hydrocortisone_NN (_( 40_CD
          ng_NN /_NN ml_NN )_) ,_, transferrin_NN (_( 5_CD μg_NN /_NN ml_NN )_) ,_, bovine_JJ serum_NN albumin_NN (_( 4_CD
          mg_NN /_NN ml_NN ,_, Bovine_NNP Albumin_NNP Fraction_NNP V_NNP ,_, albumin_NN =_SYM 95_CD %_NN )_) ,_,

          gentamicin_NN (_( 57_CD μg_NN /_NN ml_NN )_) ,_, penicillin_NN (_( 50_CD U_NNP /_NN ml_NN )_) ,_, streptomycin_NN
          (_( 50_CD μg_NN /_NN ml_NN )_) ,_, and_CC amphotericin_NN (_( 2_CD ._. 5_LS μg_NN /_NN ml_NN )_) ._. This_DT medium_NN
          significantly_RB increases_VBZ the_DT magnitude_NN and_CC duration_NN of_IN
          basal_NN and_CC FSH-stimulated_NNP progesterone_NN output_NN by_IN GC_NNP [_NN 22_CD ]_NN
          ._.
        
        
          PGC-_NNP 2_CD Cell_NNP Culture_NNP and_CC Patch_NNP Clamp_NNP
          The_DT pig_NN granulosa_NN cell_NN line_NN PGC-_NNP 2_CD was_VBD obtained_VBN from_IN
          Bruce_NNP Downey_NNP (_( McGill_NNP University_NNP )_) and_CC maintained_VBN in_IN
          culture_NN in_IN McCoy_NNP 's_POS modified_VBN 5_CD A_DT medium_NN supplemented_JJ with_IN
          10_CD %_NN FBS_NNP ,_, as_IN described_VBN previously_RB in_IN detail_NN [_NN 19_CD ]_NN ._. PGC-_NNP 2_CD
          cells_NNS have_VBP been_VBN well-characterized_JJ with_IN respect_NN to_TO
          steroidogenic_JJ capability_NN ,_, cAMP_NN response_NN ,_, and_CC gonadotropin_NN
          insensitivity_NN [_NN 19_CD ]_NN ._. Here_RB ,_, PGC-_NNP 2_CD were_VBD seeded_VBN at_IN a_DT
          density_NN of_IN approximately_RB 5_CD ×_NN 10_CD 5_CD cells_NNS /_NN ml_NN of_IN
          serum-containing_JJ medium_NN in_IN 24_CD -_: well_RB tissue_NN culture_NN plates_NNS ._.
          After_IN 24_CD h_NN the_DT medium_NN was_VBD replaced_VBN with_IN serum-free_JJ medium_NN
          containing_VBG either_CC pregnenolone_NN (_( 1_CD μg_NN /_NN ml_NN )_) ,_, androstenedione_NN
          (_( 100_CD μM_NN )_) ,_, 5_CD α-dihydrotestosterone_JJ (_( 5_CD α-_NN DHT_NNP ,_, 10_CD or_CC 100_CD μM_NN )_) ,_,
          or_CC forskolin_NN (_( 5_CD μM_NN )_) and_CC IBMX_NNP (_( 10_CD μM_NN )_) ._. To_TO ensure_VB the_DT
          validity_NN of_IN this_DT model_NN for_IN assessing_VBG the_DT functional_JJ
          effects_NNS on_IN the_DT K_NNP +_NN channel_NN antagonists_NNS ,_, we_PRP used_VBD whole-cell_JJ
          patch_NN clamp_NN techniques_NNS [_NN 4_CD ]_NN to_TO document_VB the_DT presence_NN of_IN
          4_CD -_: AP_NNP sensitive_JJ K_NNP +_NN currents_NNS in_IN PGC-_NNP 2_CD (_( see_VB additional_JJ file_NN
          1_LS )_) ._.
          Additional_JJ File_NNP 1_CD
          4_LS -_: AP-sensitive_NNP delayed_VBD rectifier_NN K_NNP +_NN current_JJ in_IN PGC-_NNP 2_CD ._.
          Whole-cell_NNP patch_NN clamp_NN currents_NNS recorded_VBN from_IN a_DT PGC-_NNP 2_CD
          cell_NN ,_, in_IN response_NN to_TO a_DT series_NN of_IN six_CD depolarizing_VBG test_NN
          pulses_NNS of_IN 1_CD s_VBZ duration_NN (_( step_NN +_NN 20_CD mV_NN )_) from_IN a_DT holding_VBG
          potential_NN of_IN -_: 50_CD mV_NN ,_, before_IN (_( left_VBD )_) and_CC after_IN (_( middle_JJ )_)
          application_NN of_IN 2_CD mM_NN 4_CD -_: aminopyridine_NN (_( 4_CD -_: AP_NNP )_) ._. The_DT right_JJ
          panel_NN shows_VBZ the_DT 4_CD -_: AP_NNP sensitive_JJ current_JJ obtained_VBN by_IN
          subtracting_VBG the_DT current_JJ traces_NNS recorded_VBN in_IN the_DT presence_NN
          (_( middle_JJ )_) of_IN the_DT drug_NN from_IN those_DT recorded_VBN in_IN the_DT absence_NN
          (_( left_VBD )_) of_IN the_DT drug_NN ._. Recording_NNP conditions_NNS are_VBP identical_JJ to_TO
          those_DT used_VBN previous_JJ by_IN our_PRP$ laboratory_NN to_TO record_VB
          voltage-dependent_JJ K_NNP +_NN currents_NNS from_IN pig_NN granulosa_NN cells_NNS (_( 
          Mol_NNP Pharmacol_NNP 2002_CD 61_CD :_: 201_CD -_: 13_CD )_) ._. The_DT
          data_NNS demonstrate_VBP that_IN PGC-_NNP 2_CD cells_NNS express_VBP K_NNP +_NN currents_NNS
          similar_JJ to_TO the_DT granulosa_NN cell_NN ultra-rapid_JJ delayed_VBN
          rectifier_NN current_JJ (_( I_NN 
          Kur_NNP )_) in_IN terms_NNS of_IN the_DT
          voltage-dependence_JJ and_CC kinetics_NNS of_IN activation_NN and_CC
          deactivation_NN ,_, as_RB well_RB as_IN the_DT sensitivity_NN to_TO 4_CD -_: AP_NNP ._. Similar_JJ
          currents_NNS were_VBD recorded_VBN in_IN 7_CD of_IN 7_CD cells_NNS assayed_JJ using_VBG
          patch-clamp_JJ techniques_NNS ._.
          Click_NNP here_RB for_IN file_NN
        
        
          Measurement_NNP of_IN Membrane_NNP Potential_JJ
          The_DT resting_VBG membrane_NN potentials_NNS of_IN cultured_JJ GC_NNP were_VBD
          assessed_VBN by_IN spectrophotometric_JJ determination_NN of_IN DiBAC_NNP 
          4_CD (_( 3_LS )_) fluorescence_NN (_( excitation_NN =_SYM 485_CD
          nM_NN ;_: emission_NN =_SYM 527_CD nM_NN ;_: Fluoroskan_NNP Ascent_NNP FL_NNP ,_, LabSystems_NNP
          Inc_NNP ._. ,_, Helsinki_NNP ,_, Finland_NNP )_) ._. Cells_NNP were_VBD equilibrated_JJ with_IN 2_CD
          μM_NN DiBAC_NNP 
          4_CD (_( 3_LS )_) for_IN 30_CD minutes_NNS at_IN 37_CD °_NN C_NNP prior_RB to_TO
          fluorescence_NN measurement_NN ._. In_IN most_JJS experiments_NNS ,_, GC_NNP were_VBD
          bathed_VBN in_IN culture_NN media_NNS ._. However_RB ,_, one_CD set_NN of_IN fluorescence_NN
          measurements_NNS compared_VBD GC_NNP incubated_JJ in_IN a_DT normal_JJ Tyrode_NNP
          solution_NN containing_VBG (_( in_IN mM_NN )_) :_: 132_CD NaCl_NNP ;_: 4_CD KCl_NNP ;_: 1_CD MgCl_NNP 
          2_CD ;_: 1_CD CaCl_NNP 
          2_CD ;_: 5_CD dextrose_NN ;_: 10_CD HEPES_NNP (_( pH_NN =_SYM 7_CD ._. 4_LS )_) to_TO
          GC_NNP similarly_RB incubated_JJ in_IN a_DT relatively_RB low-chloride_JJ
          Tyrode_NNP solution_NN in_IN which_WDT the_DT NaCl_NNP was_VBD replaced_VBN with_IN
          sodium_NN aspartate_NN ._.
        
        
          Measurement_NNP of_IN Intracellular_NNP Potassium_NNP
          Intracellular_NNP levels_NNS of_IN potassium_NN were_VBD assessed_VBN by_IN
          determination_NN of_IN PBFI_NNP fluorescence_NN ._. Cells_NNP were_VBD
          equilibrated_JJ with_IN the_DT cell_NN permeant_NN acetoxylmethyl_NN ester_NN
          of_IN the_DT ion_NN sensitive_JJ dye_NN PBFI_NNP (_( 5_CD μM_NN )_) for_IN 1_CD h_NN ,_, then_RB washed_VBN
          and_CC resuspended_JJ in_IN PBS_NNP ._. Fluorescence_NNP was_VBD measured_VBN using_VBG a_DT
          plate-reader_JJ (_( excitation_NN =_SYM 340_CD nM_NN ;_: emission_NN =_SYM 505_CD nM_NN ;_:
          Fluoroskan_NNP Ascent_NNP FL_NNP ,_, LabSystems_NNP Inc_NNP ._. ,_, Helsinki_NNP ,_,
          Finland_NNP )_) ._.
        
        
          Preparation_NNP of_IN GC_NNP Lysates_NNP
          Whole_JJ cell_NN lysates_NNS were_VBD made_VBN from_IN GC_NNP monolayers_NNS by_IN
          standard_JJ techniques_NNS using_VBG a_DT lysis_NNS buffer_NN consisting_VBG of_IN
          PBS_NNP with_IN 1_CD %_NN Nonidet_NNP P_NN 40_CD ,_, 0_CD ._. 5_CD %_NN sodium_NN deoxycholate_NN ,_, 0_CD ._. 1_CD %_NN
          SDS_NNP and_CC protease_NN inhibitor_NN cocktail_NN (_( 1_CD :_: 100_CD ,_, Sigma_NNP P_NN 8340_CD )_) ._.
          Lysis_NNP buffer_NN was_VBD added_VBN to_TO the_DT culture_NN dish_NN after_IN washing_VBG
          with_IN cold_JJ PBS_NNP 3_CD times_NNS ._. The_DT culture_NN dishes_NNS were_VBD scraped_JJ
          and_CC the_DT lysate_NN was_VBD aspirated_JJ into_IN a_DT syringe_NN with_IN a_DT
          21_CD -_: gauge_VB needle_NN to_TO shear_NN DNA_NNP ._. The_DT lysates_NNS were_VBD rocked_VBN in_IN
          the_DT cold_NN for_IN 1_CD h_NN and_CC centrifuged_JJ for_IN 10_CD min_NN at_IN 10_CD ,_, 000_CD ×_NN 
          g_SYM ._. In_IN some_DT cases_NNS ,_, a_DT highly_RB
          enriched_JJ mitochondrial_NN fraction_NN was_VBD obtained_VBN using_VBG a_DT
          commercially_RB available_JJ kit_NN (_( Mitchondrial_NNP Fractionation_NNP
          Kit_NNP ,_, Active_JJ Motif_NN ,_, Carlsbad_NNP ,_, CA_NNP )_) according_VBG to_TO the_DT
          manufacturer_NN 's_POS instructions_NNS ._. Protein_NNP concentrations_NNS of_IN GC_NNP
          lysates_NNS were_VBD determined_VBN by_IN the_DT bicinchoninic_JJ acid_NN method_NN
          (_( Micro_NNP BCA_NNP Protein_NNP Assay_NNP ,_, Pierce_NNP ,_, Rockford_NNP IL_NNP )_) ._.
        
        
          Immunoblotting_NNP
          For_IN direct_JJ comparisons_NNS of_IN protein_NN expression_NN between_IN
          drug-treated_JJ and_CC untreated_JJ cells_NNS ,_, equal_JJ amounts_NNS of_IN
          protein_NN were_VBD loaded_VBN in_IN adjacent_JJ lanes_NNS on_IN a_DT single_JJ
          polyacrylamide_NN gel_NN ,_, separated_VBN by_IN sodium_NN dodecyl_NN
          sulphate-polyacrylamide_JJ gel_NN electrophoresis_NNS (_( SDS-PAGE_NNP )_)
          under_IN reducing_VBG conditions_NNS and_CC transferred_VBN to_TO
          nitrocellulose_NN membranes_NNS by_IN the_DT semi-dry_JJ transfer_NN method_NN ._.
          The_DT membranes_NNS were_VBD blocked_VBN for_IN 1_CD h_NN at_IN room_NN temperature_NN
          with_IN 5_CD %_NN nonfat_JJ milk_NN in_IN Tris-buffered_NNP saline_NN (_( TBS_NNP :_: 100_CD mM_NN
          Tris_NNP ,_, 0_CD ._. 9_CD %_NN NaCl_NNP ,_, pH_NN 7_CD ._. 5_LS )_) containing_VBG 0_CD ._. 1_CD %_NN Tween_NNP 20_CD ,_, then_RB
          incubated_JJ overnight_JJ at_IN 4_CD °_NN C_NNP with_IN primary_JJ antibody_NN diluted_VBN
          in_IN the_DT blocking_VBG solution_NN ._. Primary_JJ antibody_NN dilutions_NNS
          were_VBD :_: PCNA_NNP (_( 1_CD :_: 200_CD )_) ;_: actin_NN (_( 1_CD :_: 500_CD )_) ;_: StAR_NNP (_( 1_CD :_: 500_CD )_) ._. After_IN
          three_CD washes_NNS with_IN 0_CD ._. 1_CD %_NN Tween_NNP /_NN TBS_NNP ,_, the_DT membranes_NNS were_VBD
          incubated_JJ for_IN 1_CD h_NN at_IN room_NN temperature_NN with_IN the_DT
          appropriate_JJ horseradish_NN peroxidase_NN conjugated_JJ secondary_JJ
          antibody_NN diluted_VBD 1_CD :_: 1500_CD in_IN 5_CD %_NN nonfat_JJ milk_NN /_NN 0_CD ._. 1_LS %_NN Tween_NNP /_NN TBS_NNP ._.
          After_IN four_CD additional_JJ washes_NNS with_IN 0_CD ._. 1_CD %_NN Tween_NNP /_NN TBS_NNP ,_, bound_VBN
          primary_JJ antibodies_NNS were_VBD visualized_JJ using_VBG an_DT ECL_NNP detection_NN
          system_NN and_CC recorded_VBN on_IN radiographic_JJ film_NN (_( Amersham_NNP
          Pharmacia_NNP Biotech_NNP )_) ._. Densitometric_NNP analysis_NN was_VBD performed_VBN
          using_VBG Scion_NNP Image_NN (_( Scion_NNP Corporation_NNP ,_, Frederick_NNP ,_, MD_NNP )_) ._.
          Equal_NNP loading_NN was_VBD confirmed_VBN by_IN either_DT immunoblotting_VBG for_IN
          actin_NN or_CC Coomassie-blue_NNP staining_VBG of_IN gel_NN lanes_NNS loaded_VBN and_CC
          subjected_VBN to_TO SDS-PAGE_NNP in_IN a_DT manner_NN identical_JJ to_TO those_DT used_VBN
          for_IN immunoblotting_VBG ._.
        
        
          Immunoassays_NNP
          Progesterone_NNP concentrations_NNS were_VBD determined_VBN by_IN a_DT
          solid-phase_JJ radioimmunoassay_NN (_( CAC_NNP Progesterone_NNP ,_,
          Diagnostic_NNP Products_NNPS Corp_NNP ,_, Los_NNP Angeles_NNP ,_, CA_NNP )_) validated_JJ for_IN
          measuring_VBG progesterone_NN in_IN the_DT culture_NN media_NNS ._. The_DT assay_NN
          sensitivity_NN was_VBD approximately_RB 0_CD ._. 3_CD ng_NN /_NN ml_NN ._. The_DT
          cross-reactivity_JJ with_IN androstenedione_NN (_( 1000_CD ng_NN /_NN mL_NN )_) was_VBD
          0_CD ._. 047_CD %_NN ._. The_DT cross-reactivity_JJ with_IN pregnenolone_NN (_( 500_CD
          ng_NN /_NN mL_NN )_) was_VBD 0_CD ._. 30_CD %_NN ._. The_DT within_IN and_CC between_IN assay_NN
          coefficients_NNS of_IN variation_NN for_IN the_DT progesterone_NN assay_NN were_VBD
          4_CD ._. 3_CD and_CC 11_CD ._. 7_CD %_NN ,_, respectively_RB ._.
          Aliquots_NNP of_IN culture_NN media_NNS were_VBD stored_VBN at_IN -_: 20_CD °_NN C_NNP for_IN up_IN
          to_TO 60_CD days_NNS prior_RB to_TO progesterone_NN assay_NN ._. In_IN the_DT initial_JJ
          series_NN of_IN experiments_NNS where_WRB serial_NN progesterone_NN
          measurements_NNS were_VBD made_VBN from_IN a_DT single_JJ culture_NN well_RB ,_, media_NNS
          progesterone_NN concentrations_NNS 24_CD -_: 48_CD hours_NNS post-treatment_JJ
          were_VBD normalized_JJ to_TO pre-treatment_JJ concentrations_NNS ._. In_IN
          subsequent_JJ experiments_NNS ,_, progesterone_NN concentrations_NNS at_IN
          various_JJ time-points_JJ post-treatment_JJ were_VBD normalized_JJ to_TO
          either_CC cell_NN number_NN or_CC protein_NN concentration_NN ._.
          Estradiol-_NNP 17_CD β_NN was_VBD measured_VBN using_VBG commercially_RB
          available_JJ reagents_NNS (_( TKE_NNP 2_CD ,_, Diagnostic_NNP Products_NNPS Corp_NNP ,_, Los_NNP
          Angeles_NNP ,_, CA_NNP )_) ._. This_DT assay_NN had_VBD been_VBN validated_JJ previously_RB
          for_IN porcine_NN serum_NN [_NN 24_CD ]_NN ,_, and_CC was_VBD further_RBR modified_VBN and_CC
          validated_JJ for_IN use_NN with_IN culture_NN media_NNS containing_VBG FBS_NNP ._. In_IN
          brief_JJ ,_, estradiol-_NN 17_CD β_NN could_MD be_VB quantitatively_RB recovered_VBN
          when_WRB added_VBD to_TO culture_NN media_NNS ,_, and_CC increasing_VBG dilutions_NNS of_IN
          media_NNS spiked_VBN with_IN estradiol-_NN 17_CD β_NN produced_VBD similar_JJ
          concentrations_NNS when_WRB evaluated_VBN in_IN the_DT assay_NN ._. The_DT
          sensitivity_NN was_VBD 4_CD ._. 9_CD pg_NN /_NN ml_NN ._. The_DT intra-_NN and_CC interassay_NN
          coefficients_NNS of_IN variation_NN for_IN estradiol_NN assay_NN were_VBD 4_CD ._. 8_CD
          and_CC 8_CD ._. 3_CD %_NN ,_, respectively_RB ._.
          Cyclic_NNP AMP_NNP was_VBD measured_VBN in_IN GC_NNP lysates_NNS using_VBG an_DT enzyme_NN
          immunoassay_NN according_VBG to_TO the_DT instructions_NNS provided_VBN by_IN the_DT
          manufacturer_NN (_( Assay_NNP Designs_NNS ,_, Ann_NNP Arbor_NNP ,_, MI_NNP )_) ._.
        
        
          Determination_NNP of_IN Cell_NNP Number_NNP
          The_DT number_NN of_IN viable_JJ GC_NNP in_IN the_DT monolayer_NN cultures_NNS was_VBD
          determined_VBN by_IN first_JJ harvesting_NN the_DT attached_VBN cells_NNS with_IN a_DT
          trypsin-containing_JJ solution_NN (_( mg_NN /_NN ml_NN )_) :_: NaCl_NNP 8_CD ;_: KCl_NNP 0_CD ._. 4_CD ;_:
          dextrose_NN 1_CD ;_: NaHCO_NNP 
          3_CD 0_CD ._. 6_CD ;_: ethylenediaminetetraacetic_JJ acid_NN
          sodium_NN salt_NN (_( Na-_NNP EDTA_NNP )_) 0_CD ._. 2_CD ;_: trypsin_NN 0_CD ._. 5_CD ,_, and_CC then_RB counting_VBG
          directly_RB the_DT number_NN of_IN viable_JJ cells_NNS using_VBG trypan_NN blue_JJ
          exclusion_NN and_CC hemacytometry_NN ._.
        
        
          Flow_NNP Cytometry_NNP
          Flow_NNP cytometry_NN was_VBD also_RB used_VBN to_TO assess_VB GC_NNP viability_NN
          and_CC size_NN ,_, using_VBG methods_NNS described_VBD previously_RB in_IN detail_NN to_TO
          determine_VB propidium_NN iodide_NN uptake_NN and_CC forward_RB (_( small_JJ
          angle_NN light_JJ )_) scatter_NN ,_, respectively_RB [_NN 18_CD 25_CD ]_NN ._. Briefly_NNP ,_,
          ten_CD thousand_CD cells_NNS were_VBD examined_VBN per_IN sample_NN using_VBG a_DT
          Becton_NNP Dickinson_NNP FACSCalibur_NNP to_TO excite_VB the_DT cells_NNS with_IN a_DT
          488_CD nM_NN argon_NN laser_NN ,_, and_CC the_DT collected_VBN data_NN obtained_VBN were_VBD
          analyzed_VBN using_VBG Cell_NNP Quest_NNP ™_NN software_NN (_( Becton_NNP Dickinson_NNP ,_,
          Mount_NNP View_NNP ,_, CA_NNP )_) ._. Changes_NNS in_IN the_DT forward_RB light_JJ scattering_VBG
          properties_NNS of_IN GC_NNP were_VBD used_VBN to_TO infer_NN changes_NNS in_IN GC_NNP size_NN ._.
          Debris_NNP ,_, shrunken_NN (_( apoptotic_JJ )_) GC_NNP and_CC dead_JJ GC_NNP stained_JJ by_IN
          propidium_NN iodide_NN were_VBD excluded_VBN from_IN analysis_NN ._.
        
        
          Statistical_NNP Analysis_NNP
          Data_NNP are_VBP expressed_VBN as_IN mean_NN ±_NN SEM_NNP unless_IN stated_VBN
          otherwise_RB ._. Statistical_NNP analysis_NN of_IN treatment_NN effects_NNS on_IN
          forward_RB scatter_NN characteristics_NNS was_VBD performed_VBN using_VBG the_DT
          non-parametric_JJ Friedman_NNP test_NN ._. For_IN all_DT other_JJ data_NN ,_,
          significant_JJ differences_NNS between_IN groups_NNS were_VBD identified_VBN by_IN
          analysis_NN of_IN variance_NN (_( ANOVA_NNP )_) using_VBG appropriate_JJ general_JJ
          linear_JJ models_NNS ,_, and_CC multiple_JJ comparisons_NNS were_VBD made_VBN using_VBG
          the_DT least_JJS significant_JJ differences_NNS (_( LSD_NNP )_) procedure_NN
          (_( Statistix_NNP ,_, Analytical_NNP Software_NNP ,_, Tallahassee_NNP ,_, FL_NNP )_) ._.
          Differences_NNS were_VBD considered_VBN to_TO be_VB significant_JJ when_WRB 
          P_NN ≤_NN 0_CD ._. 05_CD ._. The_DT numbers_NNS of_IN replicates_NNS
          per_IN treatment_NN group_NN and_CC independent_JJ experiments_NNS
          associated_VBN with_IN specific_JJ studies_NNS are_VBP provided_VBN in_IN the_DT
          figures_NNS or_CC accompanying_VBG legends_NNS ._.
        
      
      
        Results_NNS and_CC Discussion_NNP
        
          Effects_NNPS of_IN 4_CD -_: AP_NNP on_IN GC_NNP Viability_NNP and_CC Progesterone_NNP
          Production_NNP
          Treatment_NNP with_IN 4_CD -_: AP_NNP (_( 2_CD mM_NN )_) decreased_VBD progesterone_NN
          accumulation_NN in_IN the_DT media_NNS of_IN serum-supplemented_JJ GC_NNP
          cultures_NNS at_IN 24_CD h_NN and_CC 48_CD h_NN post-treatment_JJ ,_, in_IN the_DT presence_NN
          and_CC absence_NN of_IN FSH_NNP (_( Figure_NN 1_LS )_) ._. The_DT decreased_VBN progesterone_NN
          concentrations_NNS in_IN the_DT media_NNS of_IN drug-treated_JJ cultures_NNS did_VBD
          not_RB reflect_VB significant_JJ differences_NNS in_IN the_DT number_NN of_IN
          viable_JJ cells_NNS under_IN these_DT culture_NN conditions_NNS ,_, (_( Figure_NN 2_CD A_DT )_) ._.
          Densitometric_NNP analysis_NN of_IN data_NNS from_IN 3_CD experiments_NNS similar_JJ
          to_TO that_DT shown_VBN in_IN Figure_NN 2_CD Brevealed_NNP no_DT significant_JJ effect_NN
          of_IN 4_CD -_: AP_NNP treatment_NN on_IN the_DT expression_NN of_IN proliferating_VBG cell_NN
          nuclear_JJ antigen_NN (_( PCNA_NNP )_) ._. These_DT data_NNS provide_VBP additional_JJ
          evidence_NN that_IN 4_CD -_: AP_NNP exerts_NNS neither_DT an_DT anti-proliferative_JJ
          nor_CC a_DT pro-apoptotic_JJ influence_NN on_IN serum-supplemented_JJ GC_NNP
          cultures_NNS ,_, because_IN PCNA_NNP expression_NN is_VBZ a_DT sensitive_JJ marker_NN
          of_IN GC_NNP proliferation_NN and_CC apoptosis_NNS [_NN 18_CD 26_CD 27_CD ]_NN ._. The_DT lack_NN
          of_IN 4_CD -_: AP_NNP effect_NN on_IN GC_NNP viability_NN is_VBZ also_RB evident_JJ from_IN the_DT
          flow_NN cytometric_JJ analysis_NN ;_: the_DT percentages_NNS of_IN cells_NNS
          staining_VBG positive_JJ for_IN propidium_NN iodide_NN were_VBD 8_CD ±_NN 2_CD %_NN and_CC 7_CD
          ±_NN 2_CD %_NN in_IN the_DT presence_NN and_CC absence_NN of_IN drug_NN (_( n_NN =_SYM 4_CD samples_NNS
          of_IN 10_CD ,_, 000_CD cells_NNS /_NN each_DT from_IN 4_CD GC_NNP isolations_NNS )_) ._.
          Treatment_NNP with_IN 4_CD -_: AP_NNP (_( 2_CD mM_NN )_) also_RB diminished_VBN
          progesterone_NN accumulation_NN on_IN days_NNS 1_CD and_CC 2_CD post-treatment_JJ
          in_IN GC_NNP cultures_NNS maintained_VBN in_IN the_DT defined_VBN serum-free_JJ media_NNS
          in_IN the_DT presence_NN and_CC absence_NN of_IN FSH_NNP ._. However_RB ,_, in_IN these_DT
          serum-free_JJ cultures_NNS ,_, 4_CD -_: AP_NNP treatment_NN was_VBD associated_VBN with_IN
          not_RB only_RB decreased_VBD progesterone_NN accumulation_NN but_CC also_RB
          decreased_VBD numbers_NNS of_IN viable_JJ cells_NNS (_( Table_NNP 1_LS )_) ._. The_DT
          percentage_NN of_IN viable_JJ cells_NNS was_VBD unaffected_JJ by_IN 4_CD -_: AP_NNP
          (_( Control_NNP =_SYM 90_CD ±_NN 4_CD %_NN vs_NNS ._. 4_CD -_: AP_NNP =_SYM 88_CD ±_NN 4_CD %_NN ,_, n_NN =_SYM 5_CD ;_: FSH_NNP =_SYM 86_CD ±_NN
          2_CD %_NN ,_, FSH_NNP +_NN 4_CD -_: AP_NNP =_SYM 86_CD ±_NN 2_CD %_NN ,_, n_NN =_SYM 9_CD )_) ,_, suggesting_VBG that_IN 4_CD -_: AP_NNP
          inhibited_VBD growth_NN rather_RB than_IN promoted_VBN cell_NN death_NN ._.
          Overall_RB ,_, these_DT data_NNS are_VBP consistent_JJ with_IN previous_JJ
          reports_NNS that_WDT endocrine_NN cells_NNS express_VBP voltage-sensitive_JJ
          ion_NN channels_NNS that_WDT can_MD contribute_VB to_TO the_DT regulation_NN of_IN not_RB
          only_RB resting_VBG membrane_NN potential_NN and_CC cell_NN volume_NN ,_, but_CC also_RB
          cell_NN proliferation_NN and_CC steroidogenesis_NNS [_NN 12_CD 13_CD 16_CD 18_CD 21_CD
          28_CD 29_CD 30_CD 31_CD 32_CD 33_CD 34_CD 35_CD 36_CD 37_CD ]_NN ._. The_DT K_NNP +_NN currents_NNS blocked_VBN
          by_IN 4_CD -_: AP_NNP in_IN pig_NN GC_NNP are_VBP conducted_VBN by_IN ion_NN channels_NNS formed_VBN by_IN
          heteromeric_JJ complexes_NNS of_IN pore-forming_JJ subunits_NNS from_IN the_DT
          KCNA_NNP (_( also_RB called_VBN Kv_NNP 1_CD or_CC Shaker_NNP )_) family_NN of_IN proteins_NNS and_CC
          accessory_JJ subunits_NNS from_IN the_DT KCNAB_NNP (_( also_RB called_VBN Kvβ_NNP )_)
          family_NN of_IN proteins_NNS [_NN 4_CD ]_NN ._. Similar_JJ 4_CD -_: AP-sensitive_NNP K_NNP
          +_NN currents_NNS play_VBP a_DT key_JJ role_NN in_IN transduction_NN of_IN mitogenic_JJ
          signals_NNS in_IN a_DT variety_NN of_IN cell_NN types_NNS ,_, and_CC 4_CD -_: AP_NNP treatment_NN
          has_VBZ been_VBN associated_VBN with_IN not_RB only_RB growth_VB arrest_NN but_CC also_RB
          apoptosis_NNS [_NN 2_CD 3_CD 8_CD 9_CD 10_CD 14_CD 38_CD 39_CD 40_CD 41_CD 42_CD ]_NN ._.
          Our_PRP$ finding_VBG that_IN 24_CD h_NN exposure_NN to_TO 4_CD -_: AP_NNP decreased_VBD the_DT
          number_NN of_IN viable_JJ GC_NNP in_IN serum-free_JJ but_CC not_RB
          serum-supplemented_JJ primary_JJ cultures_NNS is_VBZ consistent_JJ with_IN
          the_DT reported_VBN effects_NNS of_IN 4_CD -_: AP_NNP and_CC other_JJ K_NNP +_NN channel_NN
          antagonists_NNS on_IN other_JJ cell_NN types_NNS [_NN 8_CD 43_CD 44_CD ]_NN ._. It_PRP has_VBZ been_VBN
          shown_VBN that_IN the_DT concentrations_NNS of_IN K_NNP +_NN channel_NN antagonists_NNS
          required_VBN to_TO inhibit_VB growth_NN of_IN human_JJ bladder_NN tumor_NN cells_NNS
          can_MD be_VB 70_CD times_NNS higher_JJR in_IN the_DT presence_NN than_IN the_DT absence_NN
          of_IN serum_NN [_NN 43_CD ]_NN ._. 4_CD -_: AP_NNP has_VBZ been_VBN shown_VBN to_TO inhibit_VB the_DT
          proliferation_NN of_IN human_JJ myelobastic_JJ leukemia_NN cells_NNS by_IN
          preventing_VBG growth_NN factor_NN activation_NN of_IN mitogen_NN activated_VBN
          protein_NN kinase_NN (_( MAPK_NNP )_) pathways_NNS [_NN 42_CD ]_NN ._. This_DT mechanism_NN
          may_MD be_VB responsible_JJ for_IN the_DT anti-proliferative_JJ effect_NN of_IN
          4_CD -_: AP_NNP manifest_JJ in_IN Table_NNP 1_CD ._. It_PRP is_VBZ likely_JJ that_IN MAPK_NNP pathways_NNS
          are_VBP less_RBR robust_JJ in_IN GC_NNP grown_VBN in_IN defined_VBN serum-free_JJ vs_NNS ._.
          serum-supplemented_JJ media_NNS ;_: however_RB ,_, validation_NN of_IN this_DT
          hypothesis_NNS would_MD require_VB additional_JJ experiments_NNS beyond_IN
          the_DT scope_NN of_IN the_DT present_JJ investigation_NN ._. We_PRP concluded_VBD that_IN
          the_DT anti-proliferative_JJ effect_NN of_IN 4_CD -_: AP_NNP may_MD contribute_VB to_TO
          the_DT decreased_VBN progesterone_NN accumulation_NN observed_VBD in_IN
          serum-free_JJ but_CC not_RB serum-supplemented_JJ GC_NNP cultures_NNS ,_, then_RB
          focused_VBN additional_JJ efforts_NNS on_IN understanding_VBG other_JJ
          mechanisms_NNS responsible_JJ for_IN 4_CD -_: AP_NNP inhibition_NN of_IN
          progesterone_NN production_NN ._.
          The_DT effects_NNS of_IN 4_CD -_: AP_NNP in_IN serum-supplemented_JJ GC_NNP cultures_NNS
          are_VBP consistent_JJ with_IN previous_JJ reports_NNS that_WDT antagonism_NN of_IN
          voltage-sensitive_JJ K_NNP +_NN currents_NNS can_MD modulate_VBP basal_NN and_CC
          gonadotropin-stimulated_JJ progesterone_NN accumulation_NN in_IN the_DT
          absence_NN of_IN any_DT effect_NN on_IN cell_NN growth_NN or_CC death_NN ._. We_PRP have_VBP
          shown_VBN previously_RB that_DT antagonism_NN of_IN the_DT slowly_RB activating_VBG
          non-inactivating_JJ granulosa_NN K_NNP +_NN current_JJ (_( I_NN 
          Ks_NNP )_) enhances_VBZ basal_NN progesterone_NN
          production_NN by_IN depolarizing_VBG membrane_NN potential_JJ and_CC thus_RB
          enhancing_VBG calcium_NN influx_NN via_IN pimozide-sensitive_JJ Ca_MD
          2_CD +_NN channels_NNS [_NN 18_CD ]_NN ._. In_IN contrast_NN ,_, Kusaka_NNP [_NN 21_CD ]_NN showed_VBD
          that_DT antagonism_NN of_IN 4_CD -_: AP_NNP sensitive_JJ slowly_RB inactivating_VBG
          delayed_VBN rectifier_NN K_NNP +_NN currents_NNS suppressed_VBD both_DT basal_NN and_CC
          LH-stimulated_NNP progesterone_NN production_NN ._. Data_NNP presented_VBD in_IN
          Figures_NNS 1_CD and_CC 2_CD confirm_VB the_DT inhibitory_NN effects_NNS of_IN 4_CD -_: AP_NNP on_IN
          basal_NN progesterone_NN production_NN by_IN cultured_JJ pig_NN GC_NNP ,_, and_CC
          demonstrate_VB for_IN the_DT first_JJ time_NN a_DT similar_JJ inhibitory_NN
          effect_NN of_IN 4_CD -_: AP_NNP on_IN FSH-stimulated_NNP progesterone_NN
          synthesis_NN ._.
        
        
          Effects_NNPS of_IN 4_CD -_: AP_NNP on_IN Pathways_NNP for_IN Steroid_NNP Hormone_NNP
          Biosynthesis_NNP
          The_DT inhibitory_NN action_NN of_IN 4_CD -_: AP_NNP on_IN progesterone_NN
          production_NN was_VBD investigated_VBN further_JJ using_VBG not_RB only_RB
          primary_JJ cultures_NNS ,_, but_CC also_RB the_DT spontaneously_RB established_VBN
          granulosa_NN cell_NN line_NN ,_, PGC-_NNP 2_CD [_NN 19_CD ]_NN ._. Although_IN PGC-_NNP 2_CD lack_NN
          FSH_NNP receptors_NNS ,_, these_DT cells_NNS can_MD serve_VB as_IN a_DT useful_JJ 
          in_IN vitro_NN model_NN for_IN GC_NNP function_NN ,_,
          because_IN they_PRP produce_VBP cAMP_NN in_IN response_NN to_TO forskolin_NN and_CC
          synthesize_VB progesterone_NN and_CC estradiol_NN when_WRB supplied_VBN with_IN
          appropriate_JJ substrates_NNS ._. We_PRP examined_VBD the_DT effects_NNS of_IN 4_CD -_: AP_NNP
          on_IN cAMP_NN ,_, progesterone_NN and_CC estradiol_NN production_NN by_IN PCG-_NNP 2_CD
          after_IN confirming_VBG that_IN these_DT cells_NNS express_VBP 4_CD -_: AP_NNP sensitive_JJ
          voltage-gated_JJ K_NNP +_NN currents_NNS similar_JJ to_TO those_DT in_IN primary_JJ
          cells_NNS (_( see_VB additional_JJ file_NN 1_LS )_) ._.
          4_LS -_: AP_NNP decreased_VBD production_NN of_IN cAMP_NN (_( Figure_NN 3_CD A_DT )_) ,_, and_CC
          expression_NN of_IN StAR_NNP by_IN PGC-_NNP 2_CD (_( Figure_NN 3_CD B_NNP )_) ._. 4_LS -_: AP_NNP had_VBD no_DT
          significant_JJ effect_NN on_IN progesterone_NN production_NN by_IN PCG-_NNP 2_CD
          cultured_JJ in_IN the_DT presence_NN of_IN pregnenolone_NN ,_, androstenedione_NN
          or_CC 5_CD α-_NN DHT_NNP (_( Figure_NN 4_CD A_DT )_) ._. In_IN contrast_NN ,_, 4_CD -_: AP_NNP significantly_RB
          reduced_VBD estradiol_NN production_NN by_IN PGC-_NNP 2_CD cultures_NNS provided_VBN
          with_IN androstenedione_NN (_( Figure_NN 4_CD B_NNP )_) ._.
          To_TO evaluate_VB the_DT relevance_NN of_IN the_DT experimental_JJ results_NNS
          obtained_VBD using_VBG PGC-_NNP 2_CD ,_, we_PRP examined_VBD the_DT effect_NN of_IN 4_CD -_: AP_NNP on_IN
          the_DT progesterone_NN output_NN of_IN primary_JJ GC_NNP cultures_NNS
          supplemented_JJ with_IN either_DT the_DT membrane_NN permeable_JJ cAMP_NN
          analog_NN ,_, 8_CD -_: (_( 4_CD -_: chlorophenylthio_NN )_) adenosine-_NN 3_CD '_POS ,_, 5_CD '_POS -_: cyclic_JJ
          monophosphorothioate_NN (_( 8_CD -_: CPT-cAMP_NNP ,_, 1_CD mM_NN )_) or_CC estradiol_NN 17_CD β_NN
          (_( 500_CD ng_NN /_NN ml_NN )_) ._. The_DT inhibitory_NN effect_NN of_IN 4_CD -_: AP_NNP on_IN
          progesterone_NN accumulation_NN was_VBD partially_RB but_CC not_RB
          completely_RB overcome_VBN by_IN the_DT addition_NN of_IN 8_CD -_: CPT-cAMP_NNP (_( Table_NNP
          2_LS )_) ._. 4_LS -_: AP_NNP had_VBD no_DT inhibitory_NN effects_NNS on_IN either_DT basal_NN or_CC
          FSH-stimulated_NNP progesterone_NN production_NN by_IN GC_NNP cultures_NNS
          supplemented_JJ with_IN estradiol_NN 17_CD β_NN (_( Figure_NN 5_LS )_) ._. Thereby_NNP ,_, the_DT
          combined_VBN results_NNS of_IN experiments_NNS performed_VBD using_VBG PGC-_NNP 2_CD and_CC
          primary_JJ GC_NNP cultures_NNS suggest_VBP that_IN 4_CD -_: AP-inhibition_NNP of_IN GC_NNP
          progesterone_NN production_NN may_MD be_VB linked_VBN to_TO decreased_VBD
          expression_NN of_IN StAR_NNP ,_, decreased_VBD generation_NN of_IN cAMP_NN ,_, and_CC
          decreased_VBD output_NN of_IN estradiol_NN ._.
          StAR_NNP plays_VBZ a_DT key_JJ role_NN in_IN the_DT initial_JJ steps_NNS of_IN
          steroidogenesis_NNS ,_, because_IN it_PRP is_VBZ required_VBN for_IN transport_NN of_IN
          cholesterol_NN to_TO the_DT inner_JJ mitochondrial_NN membrane_NN where_WRB
          CYP_NNP 11_CD A_DT 1_CD resides_VBZ and_CC the_DT first_JJ reaction_NN in_IN progesterone_NN
          synthesis_NN occurs_VBZ [_NN 45_CD ]_NN ._. cAMP_NN is_VBZ a_DT well_RB known_VBN second_JJ
          messenger_NN in_IN FSH-_NNP and_CC LH-stimulated_NNP progesterone_NN
          synthesis_NN ,_, and_CC a_DT key_JJ effect_NN of_IN the_DT cAMP-dependent_JJ protein_NN
          kinase_NN in_IN GC_NNP is_VBZ transcriptional_NN control_NN of_IN StAR_NNP [_NN 46_CD 47_CD ]_NN
          ._. Estradiol_NNP is_VBZ recognized_VBN as_IN a_DT biological_JJ amplifier_NN of_IN
          basal_NN ,_, FSH-_NNP and_CC cAMP-stimulated_JJ progesterone_NN production_NN
          in_IN pig_NN GC_NNP ,_, with_IN significant_JJ synergistic_JJ effects_NNS distal_NN to_TO
          the_DT generation_NN of_IN cAMP_NN at_IN one_CD or_CC more_JJR steps_NNS in_IN
          cholesterol_NN transport_NN and_CC metabolism_NN [_NN 48_CD ]_NN ._. Our_PRP$
          experimental_JJ results_NNS are_VBP thus_RB consistent_JJ with_IN 4_CD -_: AP_NNP
          inhibition_NN of_IN GC_NNP progesterone_NN output_NN via_IN drug_NN effects_NNS on_IN
          multiple_JJ interacting_VBG sites_NNS in_IN the_DT steroidogenic_JJ pathway_NN ._.
          Moreover_RB ,_, despite_IN multiple_JJ sites_NNS of_IN action_NN ,_, the_DT drug_NN 's_POS
          actions_NNS cannot_NN be_VB dismissed_VBN as_IN non-specific_JJ ,_, because_IN 4_CD -_: AP_NNP
          had_VBD no_DT effects_NNS on_IN either_DT 3_CD β-hydroxysteroid_JJ dehydrogenase_NN
          (_( 3_CD β-_NN HSD_NNP )_) -_: mediated_JJ conversion_NN of_IN pregnenolone_NN to_TO
          progesterone_NN ,_, or_CC androgen_NN (_( androstenedione_NN ,_,
          5_CD αDHT_NN )_) -_: stimulated_VBN progesterone_NN synthesis_NN ._.
          Estradiol_NNP has_VBZ been_VBN reported_VBN to_TO affect_VB K_NNP +_NN channel_NN
          expression_NN and_CC gating_VBG in_IN smooth_JJ muscle_NN [_NN 49_CD 50_CD 51_CD 52_CD 53_CD ]_NN
          ._. The_DT data_NNS presented_VBN here_RB do_VBP not_RB address_VB directly_RB the_DT
          potential_NN for_IN estradiol_NN modulation_NN of_IN voltage-gated_JJ K_NNP
          +_NN channel_NN expression_NN or_CC activity_NN in_IN GC_NNP ._. However_RB ,_, such_JJ a_DT
          mechanism_NN seems_VBZ unlikely_JJ to_TO account_VB for_IN the_DT ability_NN of_IN
          estradiol_NN to_TO oppose_VB the_DT inhibitory_NN effects_NNS of_IN 4_CD -_: AP_NNP on_IN GC_NNP
          progesterone_NN production_NN ._. The_DT K_NNP +_NN channel_NN subunits_NNS and_CC
          currents_NNS modulated_JJ by_IN estradiol_NN in_IN vascular_NN and_CC uterine_NN
          smooth_JJ muscle_NN differ_VB from_IN the_DT 4_CD -_: AP_NNP sensitive_JJ KCNA_NNP family_NN
          channels_NNS that_WDT contribute_VBP to_TO the_DT 4_CD -_: AP_NNP sensitive_JJ current_JJ I_PRP 
          Kur_NNP in_IN pig_NN GC_NNP [_NN 4_CD 49_CD 50_CD 52_CD 53_CD ]_NN ._.
          Moreover_RB ,_, in_IN the_DT single_JJ study_NN where_WRB estradiol_NN was_VBD shown_VBN
          to_TO influence_VB the_DT gating_VBG of_IN a_DT uterine_NN delayed_VBD rectifier_NN
          current_JJ with_IN electrophysiological_JJ characteristics_NNS
          resembling_VBG those_DT of_IN GC_NNP I_PRP 
          Kur_NNP ,_, the_DT observed_VBN effect_NN of_IN the_DT
          hormone_NN was_VBD inhibitory_NN [_NN 51_CD ]_NN ,_, and_CC thereby_RB similar_JJ
          rather_RB than_IN opposite_JJ to_TO the_DT effect_NN of_IN 4_CD -_: AP_NNP ._.
          Additional_JJ experiments_NNS were_VBD performed_VBN in_IN an_DT attempt_NN to_TO
          identify_VB signaling_VBG pathways_NNS that_WDT transduce_NN specific_JJ
          inhibitory_NN effects_NNS of_IN 4_CD -_: AP_NNP ._. These_DT focused_VBN on_IN 4_CD -_: AP_NNP
          modulation_NN of_IN membrane_NN potential_JJ ,_, intracellular_NN ion_NN
          concentrations_NNS ,_, and_CC cell_NN size_NN ,_, as_IN described_VBN below_IN ._.
        
        
          Effects_NNPS of_IN 4_CD -_: AP_NNP on_IN Membrane_NNP Potential_JJ ,_,
          Intracellular_NNP Ions_NNP ,_, Cell_NNP Size_NN
          Hormonal_NNP signal_NN transduction_NN and_CC steroidogenesis_NNS can_MD
          be_VB affected_VBN by_IN changes_NNS in_IN intracellular_NN and_CC extracellular_NN
          concentrations_NNS of_IN inorganic_JJ ions_NNS ,_, cellular_JJ resting_VBG
          membrane_NN potential_JJ ,_, and_CC cell_NN size_NN [_NN 29_CD 30_CD 35_CD 54_CD 55_CD 56_CD 57_CD
          58_CD 59_CD ]_NN ._. Blockade_NNP of_IN 4_CD -_: AP_NNP sensitive_JJ K_NNP +_NN channels_NNS in_IN
          non-nerve_JJ ,_, non-muscle_JJ cells_NNS can_MD lead_VB to_TO changes_NNS in_IN
          transmembrane_NN ion_NN gradients_NNS ,_, membrane_NN potential_NN and_CC cell_NN
          volume_NN [_NN 42_CD 60_CD ]_NN ._. On_IN this_DT basis_NN ,_, we_PRP determined_VBD the_DT
          effects_NNS of_IN 24_CD h_NN exposure_NN to_TO 4_CD -_: AP_NNP on_IN GC_NNP size_NN ,_, membrane_NN
          potential_NN and_CC intracellular_NN potassium_NN (_( [_NN K_NNP +_NN ]_NN 
          in_IN )_) ._.
          Samples_NNP (_( 10_CD ,_, 000_CD cells_NNS )_) of_IN GC_NNP from_IN 24_CD hour_NN cultures_NNS
          associated_VBN with_IN 4_CD GC_NNP isolations_NNS were_VBD analyzed_VBN by_IN flow_NN
          cytometry_NN to_TO determine_VB if_IN 4_CD -_: AP_NNP treatment_NN influenced_VBD GC_NNP
          size_NN ._. Light_NNP scattering_VBG properties_NNS did_VBD not_RB differ_VB
          significantly_RB with_IN GC_NNP isolate_VB ._. However_RB ,_, the_DT average_NN
          forward_RB scatter_NN (_( median_JJ ,_, coefficient_NN of_IN variation_NN )_) of_IN GC_NNP
          cultured_JJ for_IN 24_CD hours_NNS in_IN the_DT presence_NN of_IN 4_CD -_: AP_NNP (_( 768_CD ,_, 15_CD %_NN )_)
          was_VBD significantly_RB greater_JJR than_IN that_DT of_IN GC_NNP maintained_VBD
          similarly_RB in_IN the_DT absence_NN of_IN drug_NN (_( 694_CD ,_, 15_CD %_NN )_) ._.
          Representative_NNP dot_VBP plots_NNS are_VBP shown_VBN in_IN Figure_NN 6_CD ._. Resting_NNP
          membrane_NN potential_JJ (_( Figure_NN 7_CD A_DT )_) and_CC [_NN K_NNP +_NN ]_NN 
          in_IN (_( Figure_NN 7_CD B_NNP )_) were_VBD also_RB found_VBN to_TO be_VB
          increased_VBN in_IN GC_NNP exposed_VBD to_TO 4_CD -_: AP_NNP ,_, based_VBN on_IN DiBAC_NNP 
          4_CD (_( 3_LS )_) and_CC PBFI_NNP fluorescence_NN ,_,
          respectively_RB ._.
          The_DT observed_VBD drug-induced_JJ increases_NNS in_IN cell_NN size_NN and_CC
          [_NN K_NNP +_NN ]_NN 
          in_IN suggest_VBP that_IN 4_CD -_: AP_NNP sensitive_JJ K_NNP
          +_NN channels_NNS represent_VBP a_DT significant_JJ K_NNP +_NN efflux_NN pathway_NN
          involved_VBN in_IN maintenance_NN of_IN cell_NN volume_NN in_IN GC_NNP ._.
          Interestingly_RB ,_, the_DT increased_VBN [_NN K_NNP +_NN ]_NN 
          in_IN may_MD contribute_VB directly_RB to_TO the_DT
          inhibitory_NN effects_NNS of_IN 4_CD -_: AP_NNP on_IN production_NN of_IN cAMP_NN and_CC
          progesterone_NN ._. Loss_NN of_IN K_NNP +_NN from_IN the_DT intracellular_NN
          compartment_NN of_IN rat_NN GC_NNP has_VBZ been_VBN associated_VBN with_IN opposite_JJ
          effects_NNS ,_, namely_RB enhanced_JJ synthesis_NN of_IN both_DT cAMP_NN and_CC
          progesterone_NN [_NN 61_CD ]_NN ._.
          The_DT observed_VBN increase_NN (_( hyperpolarization_NN )_) of_IN GC_NNP
          resting_VBG membrane_NN potential_JJ cannot_NN be_VB explained_VBN easily_RB by_IN
          any_DT direct_JJ effect_NN of_IN the_DT drug_NN ._. In_IN fact_NN ,_, 4_CD -_: AP_NNP inhibition_NN
          of_IN K_NNP +_NN efflux_NN would_MD be_VB expected_VBN to_TO depolarize_NN rather_RB than_IN
          hyperpolarize_NN membrane_NN potential_JJ ._. Data_NNP obtained_VBD
          previously_RB in_IN our_PRP$ laboratory_NN suggest_VBP that_DT inhibition_NN of_IN
          granulosa_NN I_PRP 
          Kur_NNP should_MD be_VB associated_VBN with_IN a_DT +_NN 10_CD to_TO
          +_NN 20_CD mV_NN depolarization_NN of_IN cell_NN resting_VBG membrane_NN potential_JJ ;_:
          block_NN of_IN I_PRP 
          Ks_NNP alone_RB decreased_VBD resting_VBG potential_JJ
          by_IN +_NN 10_CD mV_NN while_IN block_NN of_IN both_DT I_PRP 
          Ks_NNP and_CC I_PRP 
          Kur_NNP decreased_VBD resting_VBG potential_JJ by_IN +_NN 20_CD
          to_TO +_NN 30_CD mV_NN [_NN 18_CD ]_NN ._. Most_JJS previous_JJ investigations_NNS of_IN 4_CD -_: AP_NNP
          effects_NNS on_IN the_DT resting_VBG membrane_NN potentials_NNS of_IN non-nerve_JJ ,_,
          non-muscle_JJ cells_NNS have_VBP similarly_RB demonstrated_VBN drug-induced_JJ
          depolarization_NN [_NN 42_CD 60_CD ]_NN ,_, although_IN there_EX is_VBZ a_DT single_JJ
          report_NN showing_VBG 4_CD -_: AP-induced_NNP hyperpolarization_NN of_IN
          chondrocyte_NN membrane_NN potential_JJ [_NN 62_CD ]_NN ._.
          We_PRP hypothesized_VBN that_DT hyperpolarization_NN of_IN 4_CD -_: AP-treated_NNP
          GC_NNP could_MD reflect_VB anion_NN influx_NN associated_VBN with_IN activation_NN
          of_IN a_DT Cl_NNP -_: entry_NN pathway_NN sensitive_JJ to_TO changes_NNS in_IN cell_NN
          volume_NN as_RB well_RB as_IN membrane-potential_JJ ._. To_TO test_VB this_DT
          hypothesis_NNS ,_, the_DT effects_NNS of_IN 4_CD -_: AP_NNP on_IN membrane_NN potential_NN
          were_VBD examined_VBN using_VBG GC_NNP incubated_JJ in_IN either_DT media_NNS modified_VBN
          to_TO contain_VB the_DT chloride_NN channel_NN antagonist_NN DIDS_NNP ,_, or_CC a_DT
          physiological_JJ buffer_NN solution_NN modified_VBN to_TO contain_VB a_DT low_JJ
          (_( 8_CD mM_NN )_) concentration_NN of_IN chloride_NN ._. In_IN contrast_NN to_TO the_DT
          results_NNS obtained_VBN in_IN the_DT standard_JJ media_NNS (_( Figure_NN 7_CD A_DT )_) ,_, 4_CD -_: AP_NNP
          did_VBD not_RB induce_VB significant_JJ hyperpolarization_NN of_IN GC_NNP under_IN
          these_DT conditions_NNS (_( Figure_NN 8_CD A_DT ,_, 8_CD B_NNP )_) ._. Exposure_NNP to_TO DIDS_NNP alone_RB
          significantly_RB decreased_VBD (_( depolarized_JJ )_) GC_NNP resting_VBG membrane_NN
          potential_JJ (_( Figure_NN 8_CD B_NNP )_) ,_, suggesting_VBG that_IN an_DT outward_RB
          chloride_NN current_JJ (_( chloride_NN influx_NN )_) contributes_VBZ to_TO the_DT
          normal_JJ resting_VBG potential_NN of_IN pig_NN GC_NNP ._. Membrane_NNP potential_NN
          was_VBD further_JJ depolarized_JJ in_IN GC_NNP exposed_VBD to_TO 4_CD -_: AP_NNP in_IN the_DT
          presence_NN of_IN DIDS_NNP (_( Figure_NN 8_CD B_NNP )_) ,_, consistent_JJ with_IN the_DT
          hypothesis_NNS that_IN 4_CD -_: AP-induced_NNP hyperpolarization_NN depends_VBZ on_IN
          chloride_NN influx_NN ._.
          Interestingly_RB ,_, concomitant_NN exposure_NN to_TO DIDS_NNP prevented_VBD
          4_CD -_: AP_NNP from_IN diminishing_VBG the_DT accumulation_NN of_IN progesterone_NN in_IN
          GC_NNP culture_NN media_NNS (_( Figure_NN 8_CD C_NNP )_) ,_, suggesting_VBG that_DT chloride_NN
          influx_NN ,_, membrane_NN hyperpolarization_NN or_CC both_DT might_MD mediate_VB
          this_DT effect_NN of_IN 4_CD -_: AP_NNP ._. Chloride_NNP channels_NNS or_CC chloride_NN ions_NNS
          are_VBP known_VBN to_TO influence_VB cAMP-stimulated_JJ steroidogenesis_NNS by_IN
          adrenal_NN cells_NNS [_NN 29_CD ]_NN ,_, human_JJ chorionic_JJ gonadotropin_NN
          (_( hCG_NN )_) -_: stimulated_VBN steroidogenesis_NNS by_IN amphibian_NN
          follicle-enclosed_JJ oocytes_NNS [_NN 56_CD ]_NN ,_, as_RB well_RB as_IN
          LH-stimulated_NNP steroidogenesis_NNS in_IN rat_NN Leydig_NNP cells_NNS [_NN 29_CD ]_NN
          ,_, MA-_NNP 10_CD cells_NNS [_NN 59_CD ]_NN ,_, and_CC chicken_NN GC_NNP [_NN 35_CD ]_NN ._. In_IN
          mammalian_JJ cells_NNS ,_, removal_NN of_IN extracellular_NN chloride_NN
          stimulates_NNS basal_NN and_CC protein_NN kinase_NN A_DT (_( PKA_NNP )_) -_: dependent_JJ
          steroid_NN hormone_NN production_NN by_IN increasing_VBG the_DT expression_NN
          of_IN StAR_NNP and_CC potentiating_VBG the_DT effects_NNS of_IN submaximal_NN
          concentrations_NNS of_IN cAMP_NN [_NN 29_CD 59_CD ]_NN ._. The_DT proposed_VBN mechanism_NN
          of_IN action_NN involves_VBZ chloride_NN efflux_NN ,_, depolarization_NN of_IN the_DT
          mitochondrial_NN and_CC plasma_NN membranes_NNS ,_, and_CC alterations_NNS to_TO
          protein_NN synthesis_NN and_CC cholesterol_NN transport_NN [_NN 29_CD 59_CD ]_NN
          ._.
          The_DT data_NNS shown_VBN here_RB in_IN Figures_NNS 7_CD and_CC 8_CD suggest_VBP strongly_RB
          that_IN chloride_NN ions_NNS can_MD influence_VB progesterone_NN production_NN
          in_IN pig_NN GC_NNP by_IN similar_JJ mechanisms_NNS ._. In_IN our_PRP$ experiments_NNS ,_, the_DT
          chloride_NN influx_NN and_CC membrane_NN hyperpolarization_NN associated_VBN
          with_IN 4_CD -_: AP_NNP treatment_NN not_RB only_RB decreased_VBD expression_NN of_IN
          StAR_NNP ,_, but_CC also_RB inhibited_VBD cAMP_NN production_NN and_CC
          steroidogenesis_NNS ._. The_DT observed_VBD effects_NNS of_IN Cl_NNP -_: channel_NN
          antagonists_NNS differ_VBP significantly_RB between_IN the_DT present_JJ
          study_NN where_WRB DIDS_NNP prevented_VBD 4_CD -_: AP_NNP from_IN decreasing_VBG
          progesterone_NN synthesis_NN and_CC previous_JJ investigations_NNS where_WRB
          DIDS_NNP and_CC other_JJ Cl_NNP -_: channel_NN antagonists_NNS prevented_VBD LH_NNP from_IN
          enhancing_VBG progesterone_NN production_NN [_NN 29_CD 35_CD 56_CD ]_NN ._. However_RB ,_,
          this_DT discrepancy_NN is_VBZ expected_VBN ,_, because_IN DIDS_NNP antagonizes_NNS a_DT
          chloride_NN influx_NN pathway_NN in_IN pig_NN GC_NNP ,_, and_CC chloride_NN efflux_NN
          pathways_NNS in_IN Leydig_NNP cells_NNS ._.
          In_IN summary_NN ,_, the_DT data_NNS demonstrate_VBP that_IN 4_CD -_: AP_NNP inhibits_NNS
          basal_NN and_CC FSH-stimulated_NNP progesterone_NN production_NN by_IN pig_NN
          GC_NNP via_IN a_DT complex_JJ mechanism_NN involving_VBG drug_NN action_NN at_IN
          multiple_JJ interacting_VBG steps_NNS in_IN the_DT steroidogenic_JJ pathway_NN ._.
          Drug_NNP block_NN of_IN the_DT voltage-gated_JJ potassium_NN channels_NNS that_WDT
          conduct_NN the_DT ultra-rapid_JJ delayed_VBN rectifier_NN current_JJ I_PRP 
          Kur_NNP is_VBZ associated_VBN with_IN increased_VBN
          intracellular_NN potassium_NN concentration_NN ,_, increased_VBN cell_NN
          volume_NN ,_, activation_NN of_IN chloride_NN influx_NN and_CC
          hyperpolarization_NN of_IN resting_VBG membrane_NN potential_JJ ._. These_DT
          changes_NNS in_IN the_DT GC_NNP internal_JJ milieu_NN appear_VBP to_TO modulate_VBP the_DT
          inhibitory_NN effects_NNS of_IN 4_CD -_: AP_NNP on_IN expression_NN of_IN StAR_NNP and_CC
          production_NN of_IN steroid_NN hormones_NNS ._.
          The_DT physiological_JJ implications_NNS of_IN the_DT data_NNS are_VBP
          significant_JJ ,_, as_IN they_PRP suggest_VBP novel_NN roles_NNS for_IN granulosa_NN
          cell_NN ion_NN channels_NNS ._. We_PRP demonstrate_VBP for_IN the_DT first_JJ time_NN not_RB
          only_RB that_WDT delayed_VBD rectifier_NN K_NNP +_NN channels_NNS play_VBP a_DT
          significant_JJ role_NN in_IN GC_NNP volume_NN regulation_NN ,_, but_CC also_RB that_DT
          voltage_NN and_CC /_NN or_CC volume-sensitive_JJ Cl_NNP -_: channels_NNS modulate_VBP GC_NNP
          membrane_NN potential_NN and_CC progesterone_NN production_NN ._.
          Additional_JJ experiments_NNS are_VBP required_VBN to_TO link_VB these_DT data_NNS
          obtained_VBN 
          in_IN vitro_NN to_TO functionally_RB
          significant_JJ changes_NNS in_IN GC_NNP volume_NN and_CC chloride_NN flux_NN during_IN
          normal_JJ follicular_NN development_NN ._.
        
      
      
        Conclusions_NNP
        In_IN conclusion_NN ,_, the_DT present_JJ studies_NNS indicate_VBP that_IN the_DT K_NNP
        +_NN channel_NN antagonist_NN 4_CD -_: AP_NNP inhibits_NNS basal_NN and_CC FSH-stimulated_NNP
        progesterone_NN production_NN by_IN pig_NN GC_NNP ._. Exposure_NNP to_TO 4_CD -_: AP_NNP is_VBZ
        associated_VBN with_IN decreased_VBD production_NN of_IN cAMP_NN ,_, decreased_VBD
        expression_NN of_IN StAR_NNP ,_, and_CC decreased_VBD synthesis_NN of_IN estradiol_NN ._.
        These_DT inhibitory_NN actions_NNS of_IN 4_CD -_: AP_NNP on_IN adenylate_NN cyclase_NN
        activity_NN ,_, StAR_NNP expression_NN and_CC steroidogenesis_NNS may_MD reflect_VB
        drug-induced_JJ changes_NNS in_IN the_DT intracellular_NN concentrations_NNS of_IN
        K_NNP +_NN and_CC Cl_NNP -_: and_CC the_DT GC_NNP resting_VBG membrane_NN potential_JJ ._. Further_RB
        studies_VBZ are_VBP required_VBN to_TO elucidate_NN fully_RB the_DT mechanisms_NNS
        involved_VBN ._.
        Additional_JJ investigation_NN is_VBZ warranted_VBN ._. 4_LS -_: AP_NNP is_VBZ reported_VBN
        to_TO have_VB therapeutic_JJ potential_NN for_IN the_DT relief_NN of_IN symptoms_NNS
        associated_VBN with_IN demyelinating_VBG diseases_NNS such_JJ as_IN spinal_JJ cord_NN
        injury_NN and_CC multiple_JJ sclerosis_NN [_NN 63_CD 64_CD 65_CD 66_CD 67_CD 68_CD ]_NN ._. The_DT
        drug_NN is_VBZ currently_RB being_VBG studied_VBN in_IN large_JJ scale_NN human_JJ trials_NNS
        [_NN 68_CD ]_NN ._. Drug-induced_NNP inhibition_NN of_IN steroid_NN hormone_NN
        production_NN could_MD have_VB significant_JJ effects_NNS in_IN these_DT
        patients_NNS ._. For_IN example_NN ,_, 4_CD -_: AP_NNP could_MD exacerbate_VB abnormal_JJ
        steroid_NN hormone_NN profiles_NNS associated_VBN with_IN spinal_JJ cord_NN injury_NN
        and_CC multiple_JJ sclerosis_NN ,_, and_CC thereby_RB contribute_VB to_TO
        dysmenorrhea_NN and_CC infertility_NN [_NN 69_CD 70_CD ]_NN ._.
      
      
        List_NN of_IN Abbreviations_NNP
        4_LS -_: aminopyridine_NN (_( 4_CD -_: AP_NNP )_) ;_: analysis_NN of_IN variance_NN (_( ANOVA_NNP )_) ;_:
        8_CD -_: (_( 4_CD -_: chlorophenylthio_NN )_) adenosine-_NN 3_CD '_POS ,_, 5_CD '_POS -_: cyclic_JJ
        monophosphorothioate_NN (_( 8_CD -_: CPT-cAMP_NNP )_) ;_: 4_CD '_POS ,_, 4_CD '_POS
        diisothicyanato-stilbene-_JJ 2_CD -_: 2_CD '_POS -_: disulfonic_JJ acid_NN (_( DIDS_NNP )_) ;_:
        bis-_NN (_( 1_CD ,_, 3_CD -_: dibutylbarbituric_JJ acid_NN )_) trimethine_NN oxonol_NN (_( DiBAC_NNP 
        4_CD (_( 3_LS )_) )_) ;_: 5_CD α-dihydrotestosterone_JJ (_( 5_CD α-_NN DHT_NNP )_) ;_:
        Dulbecco_NNP 's_POS modified_VBN eagle_NN 's_POS medium_NN (_( DMEM_NNP )_) ;_: enhanced_JJ
        chemiluminescence_NN (_( ECL_NNP )_) ;_: ethylenediaminetetraacetic_JJ acid_NN
        (_( EDTA_NNP )_) ;_: fetal_JJ bovine_JJ serum_NN (_( FBS_NNP )_) ;_: follicle_NN stimulating_VBG
        hormone_NN (_( FSH_NNP )_) ;_: granulosa_NN cells_NNS (_( GC_NNP )_) ;_: human_JJ chorionic_JJ
        gonadotropin_NN (_( hCG_NN )_) ;_:
        4_CD -_: (_( 2_CD -_: Hydroxyethyl_NNP )_) piperazine-_NN 1_CD -_: ethanesulfonic_JJ acid_NN (_( HEPES_NNP )_) ;_:
        3_CD β-hydroxysteroid_JJ dehydrogenase_NN (_( 3_CD β-_NN HSD_NNP )_) ;_:
        3_CD -_: isobutyl-_NN 1_CD -_: methylxanthine_NN (_( IBMX_NNP )_) ;_: least_JJS significant_JJ
        difference_NN (_( LSD_NNP )_) ;_: luteinizing_VBG hormone_NN (_( LH_NNP )_) ;_: mitogen_NN
        activated_VBN protein_NN kinase_NN (_( MAPK_NNP )_) ;_: 1_CD ,_, 3_CD -_: Benzenedicarboxylic_NNP
        acid_NN ,_,
        4_CD ,_, 4_CD '_POS -_: [_NN 1_CD ,_, 4_CD ,_, 10_CD ,_, 13_CD -_: tetraoxa-_NN 7_CD ,_, 16_CD -_: diazacyclooctadecane-_NN 7_CD ,_, 16_CD -_: diylbis_NNS (_( 5_CD -_: methoxy-_NN 6_CD ,_, 2_CD -_: benzofurandiyl_NN )_) ]_NN bis-_NN ,_,
        tetrakis_NNS [_NN (_( acetyloxy_NN )_) methyl_NN ]_NN ester_NN (_( PBFI-AM_NNP )_) ;_:
        phosphate-buffered_JJ saline_NN (_( PBS_NNP )_) ;_: proliferating_VBG cell_NN nuclear_JJ
        antigen_NN (_( PCNA_NNP )_) ;_: protein_NN kinase_NN A_DT (_( PKA_NNP )_) ;_: sodium_NN dodecyl_NN
        sulphate-polyacrylamide_JJ gel_NN electrophoresis_NNS (_( SDS-PAGE_NNP )_) ;_:
        steroidogenic_JJ acute_JJ regulatory_JJ protein_NN (_( StAR_NNP )_) ;_:
        tris-buffered_JJ saline_NN (_( TBS_NNP )_) ._.
      
      
        Authors_NNP '_'' contributions_NNS
        YL_NNP participated_VBD in_IN experimental_JJ design_NN ,_, performed_VBD all_DT
        experimental_JJ techniques_NNS ,_, and_CC played_VBD a_DT primary_JJ role_NN in_IN data_NNS
        analysis_NN and_CC interpretation_NN ._. SG_NNP provided_VBD general_JJ technical_JJ
        support_NN and_CC participated_VBD in_IN cell_NN isolation_NN and_CC culture_NN ,_,
        immunoblotting_VBG ,_, fluorescence_NN measurements_NNS and_CC flow_NN
        cytometry_NN ._. FvS_NNP performed_VBD patch_NN clamp_NN experiments_NNS and_CC
        analyses_NNS ,_, and_CC assisted_VBN with_IN preparation_NN of_IN the_DT figures_NNS and_CC
        manuscript_NN ._. DEM_NNP contributed_VBD to_TO data_NNS presented_VBN in_IN Figure_NN
        1_CD and_CC Table_NNP 1_CD ._. BMM_NNP contributed_VBD to_TO data_NNS presented_VBN in_IN Figures_NNS
        1_CD and_CC 2_CD ._. LCF_NNP conceived_VBD of_IN the_DT study_NN ,_, coordinated_VBN design_NN and_CC
        performance_NN of_IN experiments_NNS ,_, and_CC drafted_VBD the_DT manuscript_NN ._.
      
    
  
